Related Experiment Videos
Staphylococcus aureus small colony variants, electron transport and persistent infections
1Microbiology/Immunology and Medicine, 407 SMI, Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, Madison, WI 53706, USA.
International Journal of Antimicrobial Agents
|March 18, 2000
Summary
Staphylococcus aureus small colony variants (SCVs) exhibit slow growth and reduced toxin production due to electron transport deficiencies. Understanding these bacterial mutations offers new therapeutic targets for persistent, antibiotic-resistant infections.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Molecular Biology
Background:
- Staphylococcus aureus can develop into small colony variants (SCVs), a distinct bacterial sub-population.
- SCVs are characterized by slow growth, lack of pigment, altered carbohydrate metabolism, and reduced toxin production.
- This phenotype is linked to deficiencies in bacterial electron transport.
Purpose of the Study:
- To investigate the mechanisms underlying the SCV phenotype in Staphylococcus aureus.
- To explore the connection between electron transport, energy metabolism, and virulence in SCVs.
- To identify potential therapeutic targets for persistent, antibiotic-resistant staphylococcal infections.
Main Methods:
- Analysis of clinical isolates of Staphylococcus aureus SCVs.
- Investigation of mutations in menaquinone and heme biosynthesis operons affecting electron transport.
- Examination of SCV survival within host cells and their mechanisms of antibiotic resistance.
- Exploration of the link between energy metabolism (NADH, ATP) and toxin production.
Main Results:
- Common SCV mutations identified in menaquinone or heme biosynthesis operons impair electron transport.
- SCVs demonstrate enhanced survival within host cells, contributing to recurrent infections.
- A novel mechanism of antibiotic resistance in SCVs is associated with altered trans-membrane potential.
- A link exists between SCV energy metabolism and toxin production, potentially mediated by NADH and ATP levels.
Conclusions:
- Deficiencies in electron transport, often due to mutations in menaquinone or heme biosynthesis, drive the SCV phenotype.
- SCVs present unique challenges in treating persistent, antibiotic-resistant Staphylococcus aureus infections.
- Understanding the signaling pathways connecting energy metabolism and virulence in SCVs may reveal new drug targets to combat staphylococcal disease.